We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Genmab’s Arzerra in Combination with Fludarabine and Cyclophosphamide
FDA Approves Genmab’s Arzerra in Combination with Fludarabine and Cyclophosphamide
Genmab has announced the FDA’s approval of Arzerra in combination with fludarabine and cyclophosphamide for the treatment of patients with relapsed chronic lymphocytic leukemia.